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ABSTRACT 
BACKGROUND:  
Aging in Japan is advancing most rapidly in the world and 
is expected to increase demand for medical services in the 
near future. Aging is uneven and progress of aging varies 
from regions resulting in great differences in medical needs. 
In order to supply the needs for medical services, 
theJapanese government developed the “Regional 
Medical Vision”, which estimates the near future 
requirements for medical resources. However, this is a plan 
for redistribution of medical resources taking into account 
future changes of a population composition based on the 
current situation. In fact, each region has a diversity of 
medical needs, and it is difficult to use average medical 
needs even if they are adjusted by population structures. 
 
In consideration of such situation, we tried to estimate the 
social burden of major diseases of each region in order to 
estimate the medical needs. We picked up 
cerebrovascular diseases (CVD, ICD10 code: I60 - I69) and 
dementia (ICD10 code: F01, F03, G30), and calculated 
their social burden of all 47 prefectures in Japan that have 
authority for health policy. 
METHOD:  
Modifying the COI method developed by Rice D, we newly 
defined and estimated C-COI of CVD (ICD10 code: I60 - 
I69) and dementia (ICD10code: F01, F03, G30). C-COI 
consists of five parts; direct cost (medical), morbidity cost, 
mortality cost, direct cost (long term care (LTC)) and 
informal care cost (family’s burden). Direct cost (medical) 
is medical cost of each disease. Morbidity cost is 
opportunity cost for inpatient care and outpatient care. 
Mortality cost is measured as the loss of human capital 
(human capital method). These three costs are known as 
components of original cost of illness by Rice D. Direct cost  
 
(LTC) is long term care insurance benefits. Family’s burden 
is “unpaid care cost” by family, relatives and friends in-
home and in-community (opportunity cost). We calculated 
such costs at 2013/2014 prices using Japanese official 
statistics. 
RESULTS: 
 The total C-COI of CVD in Japan was about 6,177 billion 
JPY, the maximum was 621 billion JPY in Tokyo and the 
minimum was 33 billion JPY in Tottori (Tokyo/Tottori=18.8), 
whereas the total C-COI of dementia was 3,778 billion JPY, 
the maximum was 341 billion JPY in Tokyo and the minimum 
was 22 billion JPY in Tottori (Tokyo/Tottori=15.5). The C-COI 
per capita of CVD in Japan was about 48 thousand JPY, 
the maximum was 66 thousand JPY in Kagoshima and the 
minimum was 38 billion JPY in Saitama 
(Kagoshima/Saitama=1.7), whereas the total C-COI of 
dementia was 3,778 billion JPY, the maximum was 46 
thousand JPY in Shimane and the minimum was 22 
thousand JPY in Chiba (Shimane/Chiba=2.1). 
 
CONCLUSION:  
We substantiated a method to calculate the social burden 
of medical care and LTC care for each prefecture using C-
COI methods. In both diseases, a large difference was 
found in total costs per capita and components ratio 
between prefectures. The situations of social burden of 
diseases has diversity among prefectures. When estimating 
the future medical needs of each region, it is necessary to 
take each regional condition into account. 
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INTRODUCTION 
There are several definitions of the elderly, and 60 and over 
or 65 and over are commonly used. Recently, based upon 
the findings about the prevalence of disability and fragility, 
and the change of industry, where specialist and 
management skills are becoming predominant, the new 
definition of the elderly is defined as aged 75 and over, is 
gradually becoming popular. 
 
In Japan 65 years old and over people already occupies 
27.7% of the population, and 75 and over elderly occupies 
13.8% of the population. Moreover, percentage of 75 and 
over elderly is predicted to become 25% in 2060. This 
increase of the elderly population will result in expansion of 
demand for medical and long-term care (LTC) services. 
  
However, the ageing rate of society is unequal among 
regions, and speed of ageing is also unequal. Japanese 
government structure has 3 tiers, 1 central government, 47 
prefectures, and about 1900 municipalities. In Japan 
prefectures are commonly used as units of regional 
analysis, because prefectures have not changed their 
administrative divisions for 130 years, and they have 
responsibility for health services and public health 
administration. Ageing speed is unequal among such 
prefectures.[1] In the near future the speed of ageing within 
prefectures which already have high aging rate will be low, 
however, the speed of metropolitan suburban prefectures 
will be quite high and the demand for medical services and 
LTC services is predicted to increase (Fig. 1). About 60 % of 
increasing numbers of elderly from 2015 to 2025 are 
estimated to be concentrated in the top 10 prefectures 
with big cities (Fig. 2).  
  
The Japanese government has carried out 2 regional plans 
for medical services with estimated medical demand in 
each region. The first plan is a “regional medical care 
plan,” which started in 1985.[2] This plan determines the 
target number of beds which is calculated by current 
number of beds, discharge rate, population by sex and  
 
age, average length of stay in hospital, and so on. In 1985 
Japan was still in the situation of population increase, and 
the ageing of society had increased the demand for 
medical services. The regional medical plan restricted new 
hospitals to under-serviced areas, however, there were no 
impact on existing hospital beds.  
  
The second plan was “regional medical vision” which was 
formulated in 2015.[2] The regional medical vision was the 
plan for preparing medical delivery system in the near 
future where the population and the demand for acute 
care will be shrinking. The vision estimates medical care 
demand in 2025 using 2025 population structure and 
inpatients/outpatients rates of 2013. For promoting 
specialization and cooperation among hospitals, the vision 
estimated required number of beds classified by 4 bed 
types, that is, advanced acute care, acute care, recovery 
care, and chronic care beds. In 2015 Japan was already in 
the situation of population decrease, and the situation was 
estimated to shrink the demand for medical services in near 
future. In this vision, prefectures are expected to facilitate 
cooperation with financial incentives. 
  
This regional medical vision adopted the estimation of 
required number of beds classified by their functions; 
however, it was based on nation-wide 
inpatients/outpatients’ rates of 2013. Regional diversity of 
medical needs was not taken into account. So, it can be 
said that this is limited to the estimation from the point of 
view of the supply side. There is diversity of structure of 
diseases as well as structure of population among regions, 
and we need the estimation from the point of view of the 
demand side. In this study we tried to develop the method 
to estimate the burden of diseases, which shows diversity of 
structure of diseases among prefectures. We calculated 
the comprehensive cost of illness (C-COI) of 
cerebrovascular disease and dementia among 
prefectures. Incidence of the two diseases is high among 
elderly people and the cost structure seems to differ; both 
acute care and LTC care are needed for cerebrovascular 
disease, and mainly LTC care will be needed for dementia. 
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FIGURE 1. INCREASE OF 65 AND OVER POPULATION (2015-2025) 
 
FIGURE 2. INCREASE OF 65+ POPULATION (2015→2025) 
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FIGURE. 3 C-COI PER CAPITA OF CVD (2014) 
 
FIGURE. 4 C-COI PER CAPITA OF DEMENTIA (2014) 
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FIGURE. 5 C-COI PER CAPITA OF CVD AND DEMENTIA (2014) 
 
 
 
 
 
 
 
METHOD 
Modifying the cost of illness (COI) method developed by 
Rice D3-6), was used to define and estimate 
comprehensive cost of illness (C-COI) of cerebrovascular 
disease (CVD) (ICD10 code: I60 - I69) and dementia (ICD10 
code: F01, F03, G30). The comprehensive cost of illness (C-
COI) was defined as follows; 
 
C-COI = medical direst cost (MDC) + formal care cost 
(FCC) 
+ morbidity cost (MbC) + mortality cost (MtC) + 
informal care cost (ICC) 
 
MDC is the medical cost directly related to the disease, and 
includes costs associated with treatment, hospitalization, 
testing and drugs. In Japan almost all medical expenses 
are covered by the national medical insurance, and so we 
can calculate MDC by the data collected in the Survey of 
National Medical Care Insurance Services. MbC is the 
opportunity cost lost resulting from hospitalization and 
outpatient visits. MtC is measured as the loss of human 
capital (human capital method), which we got by 
multiplying the number of deaths from the disease by the 
lifetime labor value per person. These three costs are known 
as components of original cost of illness. [7-11] 
  
Original COI method has been well described as a way to 
measure the social burden of disease, however, it has the 
disadvantage that it cannot adequately measure the 
burden of chronic diseases whose LTC costs account for a 
significant portion of the social burden. C-COI method 
includes such LTC costs. LTC costs can be divided into 2 
parts; formal care cost (FCC) and informal care cost (ICC). 
FCC is the LTC cost covered by public LTC insurance which 
was introduced in 2000. ICC is the cost to the family 
resulting from LTC. ICC can be estimated by 2 different 
methods; opportunity cost approach (OCA) and 
replacement approach (RA). OCA uses family member’s 
opportunity cost lost resulting from giving care, whereas RA 
uses market price of care worker’s wage. Generally, the 
cost measured by OCA is lower than the cost measured by 
RA, because family caregivers are sometimes old whose 
labor value at market is low. In this study we used OCA. 
[12,13] 
  
The detailed calculation method is shown in Table 1. All 
calculation was done using governmental data.
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RESULT 
Figure 3 showed C-COI per capita of CVD of all 
prefectures. Vertical axis meant C-COI per capita; above 
0-line bars were medical costs and below 0 bars were LTC 
costs. The bars were arranged in descending order of 
medical costs. The highest was 66,315 JPY (Japanese Yen) 
of Kagoshima prefecture and was 1.8 times of the lowest 
prefecture (Saitama prefecture, 377,706 JPY). Average 
percentage of LTC costs to C-COI was about 56%. There 
was no correlation between medical costs and LTC costs, 
and breakdowns of C-COI were different among 
prefectures (Table 2). 
  
 
 
Figure 4 showed C-COI per capita of dementia of all 
prefectures. The highest was 45,634 JPY of Shimane 
prefecture and was 2.1 times of the lowest prefecture 
(Chiba prefecture, 21,853 JPY). As same as CVD there was 
no correlation between medical costs and LTC costs, and 
breakdowns of C-COI were also different among 
prefectures (Table 3). 
  
Figure 5 showed summation of C-COI of both diseases 
arranged in descending order. The line graph showed the 
ratio of C-COI of CVD to that of dementia. The highest was 
1.91 of Kanagawa prefecture, whereas the lowest is 1.28 of 
Oita prefecture. There was diversion in not only the level of 
C-COI but also the ratio of each disease among 
prefectures. 
TABLE 1 COST CALCULATION 
 
1.Benchmark discount rate was 3%. 
2. One day labor-value was referred from the national survey of 2014.    
3.Life time labor-value was calculated summing up the income which patient could have earned in the future if they had not died. 
TABLE 2 C-COI PER CAPITA OF CVD:  AVERAGE, MAX AND MIN 
 
Medical DC
Formal Care 
Cost
Informal 
Care Cost 
Mortality 
cost
Indirect cost
Calculation   Method
Direct cost
Annual medical expenses based on reimbursement data *.
LTC cost covered by public LTC insurance
Morbidity 
cost
(Total person-days of hospitalization× One day labor-value)
+(Total person-days of outpatient× One day labor-
number of family caregivers× average time for care a day × 
1-hour labor value per person × 365
Number of death× Life time labor-value per person
C-COI
direct 
(Med)
morbidit
y
mortalit
y
direct 
(LTC)
family`s 
burden
AVG (JPY) 51,664 12,090 2,025 8,388 14,998 14,164
SD (JPY) 7,223 3,032 518 1,217 2,557 2,329
66,315 20,363 3,965 11,487 19,844 18,941
Kagoshi
ma
Kagoshi
ma
Kagoshi
ma
Iwate Akita 
Wakaya
ma
37,706 8,045 1,335 6,310 10,035 9,507
Saitama Shiga
Yamanas
hi
Kagawa Saitama Saitama
MAX/MIN 1.8 2.5 3.0 1.8 2.0 2.0
MAX (JPY)
MIN (JPY)
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TABLE 3 C-COI PER CAPITA OF DEMENTIA:  AVERAGE, MAX AND MIN 
 
 
       
 
DISCUSSION  
The results of the study would intensify the diversity of 
ageing and corresponding burden of major diseases 
among prefectures. In an ageing society, local level health 
policy will become more important using detailed data of 
each prefecture. 
  
In this study we could estimate regional burden of diseases 
using C-COI method. C-COI of both CVD and dementia 
varied widely, moreover the breakdowns of costs also 
varied widely among prefectures. In addition to these, the 
ratio of C-COI of CVD to that of dementia also showed 
difference, and there was no correlation between C-COIs 
of two diseases. It was suggested that the structures of the 
burden of diseases differ with regions. 
  
Our study had several limitations. First, the data we used 
were governmental aggregated data, so we could not get 
the information about number of persons requiring care 
classified by major causes. In this study we used proportion 
of persons requiring care whose major cause was CVD or 
dementia to whole persons requiring care and multiplied 
the proportion by the number of persons requiring care of 
each prefecture. Second, persons requiring care were 
classified by only major causes, we could not consider the 
burden of comorbidities. Elderly people commonly have 
several diseases, and two diseases could contribute to 
lower ADLs. Our C-COI might be under-estimated since the 
contribution of two diseases as comorbidities were not 
taken into account. Finally, our C-COIs were calculated for  
 
only 2014 year. Time series analysis and future projection 
should be next issues. 
  
Despite such limitations, we expect that our measurement 
of burden of diseases in prefectures using C-COI method 
helps to estimate regional medical demand. More detailed 
analysis using governmental individual data is needed. 
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